Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

NCT04488978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Irbesartan/Amlodipine

Sponsor

Handok Inc.